Article Information
History
- January 6, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Maya F. Amjadi1,
- Sarah E. O’Connell2,
- Tammy Armbrust3,
- Aisha M. Mergaert1,4,
- Sandeep R. Narpala2,
- Peter J. Halfmann3,
- S. Janna Bashar1,
- Christopher R. Glover1,
- Anna S. Heffron4,
- Alison Taylor2,
- Britta Flach2,
- David H. O’Connor4,
- Yoshihiro Kawaoka3,
- Adrian B. McDermott2,
- Ajay K. Sethi5 and
- Miriam A. Shelef1,6,*
- 1Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705 USA
- 2Vaccine Immunology Program, Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 USA
- 3Department of Pathobiological Sciences, School of Veterinary Medicine, Influenza Research Institute, University of Wisconsin–Madison, Madison, WI 53711 USA
- 4Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53705 USA
- 5Department of Population Health Sciences, University of Wisconsin-Madison, Madison, WI 53726 USA
- 6William S. Middleton Memorial Veterans Hospital, Madison, WI 53705 USA
- ↵*Corresponding author:
Miriam A. Shelef, 4130 UW Medical Foundation Centennial Building, 1685 Highland Ave, Madison, WI 53705, (608) 263-5241, mshelef{at}medicine.wisc.edu
Posted January 06, 2021.
Fever, Diarrhea, and Severe Disease Correlate with High Persistent Antibody Levels against SARS-CoV-2
